We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

MedImaging

Download Mobile App
Recent News Radiography MRI Ultrasound Nuclear Medicine General/Advanced Imaging Imaging IT Industry News

NorthStar to Build New Production Line of Medical Radioisotopes

By MedImaging International staff writers
Posted on 09 Jun 2016
Print article
Image: The University of Missouri Research Reactor (MIRR) (Photo courtesy of the University of Missouri).
Image: The University of Missouri Research Reactor (MIRR) (Photo courtesy of the University of Missouri).
NorthStar Medical Radioisotopes (Madison, WI, USA) will construct a new filling line that will quadruple the company’s capacity to dispense molybdenum-99 (Mo-99).

The new high-capacity medical radioisotope filling line will be installed at the University of Missouri Research Reactor (MURR; Columbia, MO, USA) by Von Gahlen International (Zevenaar, The Netherlands). The system will include a high-capacity DPharm unit to fill source vessels quickly, along with companion nuclear radiation containment chambers. The vessels will then be shipped to customers for use with the RadioGenix isotope separation system.

In addition to significantly increasing dispensing capacity at MURR, the new filling line will also be able to prepare source vessels containing Mo-99 generated from natural or enriched molybdenum-98 (Mo-98) targets, which have higher concentrations of Mo-98 and produce approximately three times more Mo-99 than natural targets. Installation is scheduled to begin in November 2106, with full operability targeted for the first half of 2017.

Mo-99 is the parent isotope of technetium-99m, the most widely used radioisotope in medical diagnostic imaging. Because of its unstable nature, Mo-99 does not occur naturally, and is traditionally produced using highly enriched uranium (HEU) in aging nuclear reactors, creating safety and national security concerns and the risk of product shortages. NorthStar is investing more than USD three million in the development of new processes for producing Mo-99 without the use of HEU.

It is striving to become the first producer of Mo-99 in the United States after more than 25 years, while facing competition from SHINE Medical Technologies (SHINE; Monona, WI, USA), which is also developing an alternative production method involving bombarding a low enriched uranium (LEU) uranyl sulfate solution with fast neutrons at the linear accelerator at Argonne National Laboratory (ANL; Lemont, IL, USA).

Related Links:
NorthStar Medical Radioisotopes
University of Missouri Research Reactor
Von Gahlen International
SHINE Medical Technologies
Argonne National Laboratory
New
Gold Member
X-Ray QA Meter
T3 AD Pro
New
Table-Top Reader
FCR PRIMA T2
New
3T MRI Scanner
MAGNETOM Cima.X
New
Ultrasound Imaging System
P12 Elite

Print article
Radcal

Channels

Ultrasound

view channel
Image: Scientists have highlighted ultrasound’s potential to treat complex health conditions affecting the brain (Photo courtesy of University of Plymouth)

Ultrasound Can Identify Sources of Brain-Related Issues and Disorders Before Treatment

For many years, healthcare professionals worldwide have relied on ultrasound to monitor the growth of unborn infants and evaluate the health of internal organs. However, ultrasound technology, once primarily... Read more

Nuclear Medicine

view channel
mage: syngo.PET Cortical Analysis software enables the measurement of beta-amyloid and tau protein deposits in the brain (Photo courtesy of Siemens Healthineers)

PET Software Enhances Diagnosis and Monitoring of Alzheimer's Disease

Alzheimer’s disease is marked by the buildup of beta-amyloid plaques and tau protein tangles in the brain. These deposits of beta-amyloid and tau appear in various brain regions at differing rates as the brain ages.... Read more

General/Advanced Imaging

view channel
Image: Heavy smokers can ben Image (2):	efit from lung cancer screening using low-dose CT (Photo courtesy of 123RF)

Low-Dose CT Screening for Lung Cancer Can Benefit Heavy Smokers

Lung cancer is often diagnosed at a late stage, with only about one-fifth to one-sixth of patients surviving five years after diagnosis. A new report now suggests that low-dose computed tomography (CT)... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: The advocacy partnership aims to help accelerate access to life-saving treatments (Photo courtesy of Philips)

Philips and Medtronic Partner on Stroke Care

A stroke is typically an acute incident primarily caused by a blockage in a brain blood vessel, which disrupts the adequate blood supply to brain tissue and results in the permanent loss of brain cells.... Read more